IgG4-related retroperitoneal fibrosis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Nov 2023Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases Via Radiomics

Heidelberg University

TrialACTIVE NOT RECRUITING
Nov 2022Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis

Assistance Publique - Hôpitaux de Paris — PHASE4

TrialRECRUITING
Mar 2020National Registry of IRPF in China

Peking Union Medical College Hospital

TrialRECRUITING
Jan 2020A Prospective Cohort Study of IRPF in China

Peking Union Medical College Hospital

TrialRECRUITING
Jul 2018Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis

Peking University International Hospital — PHASE2, PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for IgG4-related retroperitoneal fibrosis.
Check the disease page for updates →

Clinical Trial Landscape

5 active trials
1Phase 4
3Unknown
1PHASE2, PHASE3
5Total recruiting
Search clinical trials for IgG4-related retroperitoneal fibrosis

Recent News & Research

No recent news articles indexed yet for IgG4-related retroperitoneal fibrosis.
Search PubMed for IgG4-related retroperitoneal fibrosis

Browse all IgG4-related retroperitoneal fibrosis news →

Specialist Network

Top 6 by expertise

View all IgG4-related retroperitoneal fibrosis specialists →

Quick Actions